Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy

The use of MRI in urothelial carcinoma

(2022) Emanuele Messina et al.   CURRENT OPINION IN UROLOGY

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

(2021) Richard J. Sylvester et al.   EUROPEAN UROLOGY

Contemporary Outcomes of Patients with Non-Muscle Invasive Bladder Cancer Treated with BCG Therapy: Implications for Clinical Trial Design

(2021) Justin T. Matulay et al.   JOURNAL OF UROLOGY

European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

(2021) Marko Babjuk et al.   EUROPEAN UROLOGY

Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy

(2021) Patrick J. Hensley et al.   JOURNAL OF UROLOGY

Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration

(2021) Chiara Lonati et al.   European Urology Focus

Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study

(2020) James W. F. Catto et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study

(2020) François-Xavier Nouhaud et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

What Is the Significance of Variant Histology in Urothelial Carcinoma?

(2019) Niyati Lobo et al.   European Urology Focus

A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer

(2018) Andrea Mari et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

(2016) Samantha Cambier et al.   EUROPEAN UROLOGY

Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group

(2016) Ashish M. Kamat et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy

(2015) Marco Moschini et al.   BJU INTERNATIONAL

Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort

(2011) Robert S. Svatek et al.   BJU INTERNATIONAL

The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer

(2008) Necole M. Streeper et al.   BJU INTERNATIONAL

Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach?

(2007) Stefan Denzinger et al.   EUROPEAN UROLOGY